IN2012DN02637A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02637A
IN2012DN02637A IN2637DEN2012A IN2012DN02637A IN 2012DN02637 A IN2012DN02637 A IN 2012DN02637A IN 2637DEN2012 A IN2637DEN2012 A IN 2637DEN2012A IN 2012DN02637 A IN2012DN02637 A IN 2012DN02637A
Authority
IN
India
Prior art keywords
plant
fraction
vlps
apoplast
derived
Prior art date
Application number
Other languages
English (en)
Inventor
Louis-Philippe Vezina
Manon Couture
Dany Paquet
Michele Dargis
Aoust Marc-Andre D
Original Assignee
Medicago Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medicago Inc filed Critical Medicago Inc
Publication of IN2012DN02637A publication Critical patent/IN2012DN02637A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02—Recovery or purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/517—Plant cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
IN2637DEN2012 2009-09-22 2010-09-21 IN2012DN02637A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24478609P 2009-09-22 2009-09-22
PCT/CA2010/001488 WO2011035422A1 (en) 2009-09-22 2010-09-21 Method of preparing plant-derived vlps

Publications (1)

Publication Number Publication Date
IN2012DN02637A true IN2012DN02637A (da) 2015-09-04

Family

ID=43795254

Family Applications (2)

Application Number Title Priority Date Filing Date
IN2637DEN2012 IN2012DN02637A (da) 2009-09-22 2010-09-21
IN2591DEN2012 IN2012DN02591A (da) 2009-09-22 2010-09-21

Family Applications After (1)

Application Number Title Priority Date Filing Date
IN2591DEN2012 IN2012DN02591A (da) 2009-09-22 2010-09-21

Country Status (27)

Country Link
US (2) US11833200B2 (da)
EP (3) EP2480560B1 (da)
JP (2) JP5554414B2 (da)
KR (4) KR101773431B1 (da)
CN (4) CN107090021A (da)
AR (2) AR078433A1 (da)
AU (2) AU2010300034B2 (da)
BR (2) BR112012006415B1 (da)
CA (2) CA2772964C (da)
DK (3) DK3354657T3 (da)
ES (3) ES2662778T3 (da)
HR (3) HRP20220478T1 (da)
HU (3) HUE058165T2 (da)
IL (4) IL218393A0 (da)
IN (2) IN2012DN02637A (da)
MX (2) MX2012003372A (da)
MY (2) MY158475A (da)
NO (2) NO2480658T3 (da)
NZ (2) NZ598481A (da)
PL (3) PL2480658T3 (da)
PT (3) PT3354657T (da)
RU (2) RU2579903C2 (da)
SG (2) SG178918A1 (da)
SI (3) SI2480658T1 (da)
TR (1) TR201803560T4 (da)
WO (2) WO2011035423A1 (da)
ZA (2) ZA201202836B (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
MX2010007962A (es) 2007-11-27 2010-11-10 Medicago Inc Particulas tipo virus de influenza recombinante (vlp) producidas en plantas transgenicas que expresan hemaglutinina.
US10272148B2 (en) 2009-06-24 2019-04-30 Medicago Inc. Chimeric influenza virus-like particles comprising hemagglutinin
PL2480658T3 (pl) 2009-09-22 2017-12-29 Medicago Inc. Sposób otrzymywania VLP pochodzenia roślinnego
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
TWI620816B (zh) * 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
CA2839009C (en) * 2011-06-13 2015-10-20 Medicago Inc. Rabies virus like particle production in plants
EP2758038B1 (en) * 2011-09-23 2018-05-30 The United States of America, as represented by The Secretary, Department of Health & Human Services Novel influenza hemagglutinin protein-based vaccines
CA2850407C (en) 2011-09-30 2021-11-23 Medicago Inc. Increasing virus-like particle yield in plants
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CN107164376B (zh) * 2011-12-21 2021-03-30 阿普斯有限责任公司 使用具有对水解酶抗性的衣壳的vlp的方法
JP6406655B2 (ja) * 2012-02-22 2018-10-17 三菱商事フードテック株式会社 植物性食品素材の軟化方法、軟化製剤、軟化した植物性食品素材およびそれを用いた食品
WO2013142329A1 (en) * 2012-03-22 2013-09-26 Fraunhofer Usa, Inc. Virus -like particles comprising a matrix protein from a plant enveloped virus and uses thereof
EP2893007B1 (en) 2012-09-05 2022-03-16 Medicago Inc. Enterovirus 71-like particles production in plants
US9617297B2 (en) * 2012-10-11 2017-04-11 The Regents Of The University Of California Apoplast wash fluid recovery for improved recombinant endoglucanase extraction in tabacco leaves
EP2978848B1 (en) * 2013-03-28 2020-05-06 Medicago Inc. Influenza virus-like particle production in plants
WO2015034042A1 (ja) * 2013-09-06 2015-03-12 三菱化学株式会社 植物を用いたタンパク質の製造方法
EP3054971B1 (en) 2013-10-11 2021-03-10 The United States of America, represented by the Secretary, Department of Health and Human Services Epstein-barr virus vaccines
RU2699982C2 (ru) 2014-01-10 2019-09-11 Медикаго Инк. Энхансерные элементы cpmv
EP3167057B1 (en) 2014-07-11 2020-03-25 Medicago Inc. Modifying protein production in plants
AU2015373928B2 (en) 2014-12-31 2019-10-17 The Usa, As Represented By The Secretary, Dept. Of Health And Human Services Novel multivalent nanoparticle-based vaccines
JP2019129705A (ja) * 2016-03-31 2019-08-08 日本たばこ産業株式会社 植物に物質を導入する方法
IL265121B2 (en) 2016-09-02 2023-11-01 Us Health Stable group 2 trimers from the stem region of influenza hemagglutinin and their uses
CA3083857A1 (en) * 2017-11-30 2019-06-06 Medicago Inc. Modified norovirus vp1 proteins and vlps comprising modified norovirus vp1 proteins
EP3821014A4 (en) 2018-07-13 2022-04-20 Medicago Inc. MODIFIED NOROVIRUS VP1 PROTEINS AND VLPS WITH MODIFIED NOROVIRUS VP1 PROTEINS
CN109112093B (zh) * 2018-09-05 2021-11-09 上海交通大学 一种青蒿原生质体高效分离及瞬时转化的方法
CN110483616B (zh) * 2019-07-31 2021-06-04 中国农业科学院农产品加工研究所 从感染病原菌的植物组织中分离病原菌分泌的质外体效应蛋白的方法
CN111060696B (zh) * 2019-12-27 2023-09-08 湖南农业大学 一种降低植物小分子信号肽假阳性率的方法
CN111718394A (zh) * 2020-06-28 2020-09-29 广西壮族自治区农业科学院 一种基于bpp法的甘蔗组织变性蛋白提取方法
CN111826394A (zh) * 2020-08-07 2020-10-27 浙江华缔药业集团医药开发有限公司 植物瞬时表达载体的构建及应用
CN117479831A (zh) 2021-06-09 2024-01-30 南特知识产权控股有限责任公司 用于在植物中生产感兴趣的蛋白质的方法和系统
CN114934007B (zh) * 2022-07-01 2023-11-24 广东省农业科学院作物研究所 一种甘薯原生质体的制备方法

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4945050A (en) 1984-11-13 1990-07-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
US5100792A (en) 1984-11-13 1992-03-31 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues
US5036006A (en) 1984-11-13 1991-07-30 Cornell Research Foundation, Inc. Method for transporting substances into living cells and tissues and apparatus therefor
WO1986003224A1 (en) 1984-11-29 1986-06-05 Scripps Clinic And Research Foundation Polypeptides and antibodies related to deglycosylated viral glycoproteins
JPS61265086A (ja) * 1985-05-21 1986-11-22 Mitsui Toatsu Chem Inc プロトプラストの培養法
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
US6403865B1 (en) 1990-08-24 2002-06-11 Syngenta Investment Corp. Method of producing transgenic maize using direct transformation of commercially important genotypes
DE69213804T2 (de) 1991-03-28 1997-03-27 Rooperol Na Nv Zusammensetzungen von Phytosterolen mit Phytosterolinen als Immunmodulatoren
UA48104C2 (uk) 1991-10-04 2002-08-15 Новартіс Аг Фрагмент днк, який містить послідовність,що кодує інсектицидний протеїн, оптимізовану для кукурудзи,фрагмент днк, який забезпечує направлену бажану для серцевини стебла експресію зв'язаного з нею структурного гена в рослині, фрагмент днк, який забезпечує специфічну для пилку експресію зв`язаного з нею структурного гена в рослині, рекомбінантна молекула днк, спосіб одержання оптимізованої для кукурудзи кодуючої послідовності інсектицидного протеїну, спосіб захисту рослин кукурудзи щонайменше від однієї комахи-шкідника
US6326470B1 (en) * 1997-04-15 2001-12-04 The Penn State Research Foundation Enhancement of accessibility of cellulose by expansins
US5762939A (en) 1993-09-13 1998-06-09 Mg-Pmc, Llc Method for producing influenza hemagglutinin multivalent vaccines using baculovirus
GB9414118D0 (en) 1994-07-13 1994-08-31 Axis Genetics Ltd Modified plant viruses as vectors of heterologous peptides
US6020169A (en) 1995-07-20 2000-02-01 Washington State University Research Foundation Production of secreted foreign polypeptides in plant cell culture
US5773695A (en) * 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6042832A (en) 1996-08-28 2000-03-28 Thomas Jefferson University Polypeptides fused with alfalfa mosaic virus or ilarvirus capsid proteins
US20010006950A1 (en) 1998-02-11 2001-07-05 Juha Punnonen Genetic vaccine vector engineering
US6489537B1 (en) 1998-08-07 2002-12-03 The Trustees Of The University Of Pennsylvania Phytochelatin synthases and uses therefor
JP2002522559A (ja) 1998-08-11 2002-07-23 ラージ スケール バイオロジー コーポレイション 植物組織の間質液からタンパク質を回収するための方法
US6287570B1 (en) 1998-11-23 2001-09-11 Patricia L. Foley Vaccine against swine influenza virus
AU2594300A (en) 1998-12-23 2000-07-12 Samuel Roberts Noble Foundation, Inc., The Plant transformation process
FR2791358B1 (fr) 1999-03-22 2003-05-16 Meristem Therapeutics Promoteurs chimeriques d'expression, cassettes d'expression, plasmides, vecteurs, plantes et semences transgeniques les contenant et leurs methodes d'obtention
NZ513993A (en) 1999-04-21 2001-09-28 Samuel Roberts Noble Found Inc Plant transformation process
US7125978B1 (en) 1999-10-04 2006-10-24 Medicago Inc. Promoter for regulating expression of foreign genes
WO2002012454A1 (fr) * 2000-08-08 2002-02-14 The Kitasato Institute Micrograins de type viral et procede de production correspondant
US7449188B2 (en) 2001-01-18 2008-11-11 Vlaams Interuniversitair Instituut Voor Biotechnologie Recombinant oligometric protein complexes with enhanced immunogenic potential
US20050037420A1 (en) 2001-09-14 2005-02-17 Mei-Yun Zhang Immunoglobulin having particular framework scaffold and methods of making and using
EP3009507B1 (en) 2002-02-13 2020-06-24 Wisconsin Alumini Research Foundation Signal for packaging of influenza virus vectors
AU2003219760A1 (en) 2002-02-14 2003-09-04 Novavax, Inc. Optimization of gene sequences of virus-like particles for expression in insect cells
CA2819867A1 (en) 2002-03-19 2003-09-25 Stichting Dienst Landbouwkundig Onderzoek Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants
US7132291B2 (en) 2003-05-05 2006-11-07 Dow Agro Sciences Llc Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
WO2004098530A2 (en) 2003-05-05 2004-11-18 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
CA2816222A1 (en) 2003-06-16 2005-03-03 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
US8592197B2 (en) 2003-07-11 2013-11-26 Novavax, Inc. Functional influenza virus-like particles (VLPs)
CN1560227A (zh) * 2004-02-25 2005-01-05 福建师范大学 雨生红球藻原生质体制备与再生技术
US7901691B2 (en) 2004-08-13 2011-03-08 Council Of Scientific And Indistrial Research Chimeric G protein based rabies vaccine
US9155483B2 (en) 2004-12-03 2015-10-13 The Invention Science Fund I, Llc Vision modification with reflected image
EP2949756A3 (en) * 2005-03-15 2016-02-24 BP Corporation North America Inc. Cellulases, nucleic acids encoding them and methods for making and using them
EP2374892B1 (en) 2005-04-29 2018-02-14 University of Cape Town Expression of viral proteins in plants
CN100410378C (zh) 2005-05-09 2008-08-13 中国农业科学院生物技术研究所 编码禽流感血凝素的基因及其植物表达载体和应用
EP1896596B1 (en) * 2005-06-24 2011-09-07 Bayer BioScience N.V. Methods for altering the reactivity of plant cell walls
EP1909829A4 (en) 2005-07-19 2009-11-11 Dow Global Technologies Inc RECOMBINANT GRIP VACCINES
US7871626B2 (en) 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
PT1937301E (pt) 2005-10-18 2015-09-14 Novavax Inc Partículas idênticas a vírus (vlps) da gripe funcionais
ES2514316T3 (es) * 2005-11-22 2014-10-28 Novartis Vaccines And Diagnostics, Inc. Partículas similares a virus (VLPs) de Norovirus y Sapovirus
BRPI0707733B1 (pt) 2006-02-13 2019-12-31 Fraunhofer Usa Inc antígeno isolado, composição de vacina, uso da referida composição e método para produção de uma proteína de antígeno
AR060565A1 (es) 2006-04-21 2008-06-25 Dow Agrosciences Llc Vacuna para la gripe aviaria y metodos de uso
US8778353B2 (en) 2006-05-01 2014-07-15 Technovax, Inc. Influenza virus-like particle (VLP) compositions
DK2023952T3 (da) 2006-05-18 2015-10-19 Epimmune Inc Induktion af immunresponser mod influenzavirus ved anvendelse af polypeptid- og nukleinsyre-sammensætninger
EP2029755A1 (en) 2006-05-22 2009-03-04 Plant Bioscience Limited Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
US20070286873A1 (en) 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
WO2008088813A1 (en) 2007-01-17 2008-07-24 Lerner Medical Devices, Inc. Fiber optic phototherapy device
US7730950B2 (en) 2007-01-19 2010-06-08 Halliburton Energy Services, Inc. Methods for treating intervals of a subterranean formation having variable permeability
US20110008837A1 (en) 2007-06-15 2011-01-13 Marc-Andre D-Aoust Modifying glycoprotein production in plans
KR100964462B1 (ko) 2007-07-10 2010-06-16 성균관대학교산학협력단 형질전환 식물 유래의 조류독감 바이러스 백신 및 그 제조방법
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
RU2358981C2 (ru) * 2007-08-07 2009-06-20 Центр "Биоинженерия" Российской Академии Наук Универсальная вакцина против вируса гриппа птиц
CA2696764A1 (en) 2007-08-20 2009-02-26 Fraunhofer Usa, Inc. Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
CN101422128B (zh) * 2007-10-29 2011-06-08 中国水产科学研究院黄海水产研究所 马尾藻原生质体的分离和再生
MX2010007962A (es) 2007-11-27 2010-11-10 Medicago Inc Particulas tipo virus de influenza recombinante (vlp) producidas en plantas transgenicas que expresan hemaglutinina.
US8933013B2 (en) 2007-12-05 2015-01-13 Nono Inc. Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
JP2011508034A (ja) * 2007-12-28 2011-03-10 ユニリーバー・ナームローゼ・ベンノートシヤープ 茶から香気成分を回収する方法
US8799801B2 (en) 2008-01-16 2014-08-05 Qualcomm Incorporated Interactive ticker
KR101956910B1 (ko) 2008-01-21 2019-03-12 메디카고 인코포레이티드 헤마글루티닌을 발현하는 트랜스제닉 식물에서 생산된 재조합 인플루엔자 바이러스-유사 입자(ＶＬＰｓ)
US8771703B2 (en) 2008-07-08 2014-07-08 Medicago Inc. Soluble recombinant influenza antigens
CN101626276A (zh) 2008-07-10 2010-01-13 华为技术有限公司 广告替换方法、装置及系统
MX370690B (es) 2008-07-18 2019-12-19 Medicago Inc Epitopo de inmunizacion de nuevo virus de la influenza.
WO2010025285A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
WO2010042551A2 (en) * 2008-10-06 2010-04-15 Genvault Corporation Methods for providing cellular lysates from cell wall-containing samples
WO2010077712A1 (en) 2008-12-09 2010-07-08 Novavax, Inc. Bovine respiratory syncytial virus virus-like particle (vlps)
JP2012516452A (ja) 2009-01-30 2012-07-19 エイディーライフ インコーポレイティッド 立体構造的に動的なペプチド
AU2010259984B2 (en) 2009-06-10 2017-03-09 Arbutus Biopharma Corporation Improved lipid formulation
US10272148B2 (en) 2009-06-24 2019-04-30 Medicago Inc. Chimeric influenza virus-like particles comprising hemagglutinin
PL2480658T3 (pl) 2009-09-22 2017-12-29 Medicago Inc. Sposób otrzymywania VLP pochodzenia roślinnego
CN103282501A (zh) 2010-11-04 2013-09-04 麦迪卡格公司 植物表达系统
DK2635257T3 (da) 2010-11-05 2017-09-04 Novavax Inc Rabiesvirus-lignende glycoproteinpartikler (vlp)
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法

Also Published As

Publication number Publication date
MX2012003373A (es) 2012-05-29
ES2642631T3 (es) 2017-11-17
IN2012DN02591A (da) 2015-08-28
KR102115226B1 (ko) 2020-05-27
IL218422B (en) 2018-03-29
DK3354657T3 (da) 2022-04-19
EP3354657A1 (en) 2018-08-01
CN102549148A (zh) 2012-07-04
SI3354657T1 (sl) 2022-05-31
WO2011035422A1 (en) 2011-03-31
PT2480560T (pt) 2018-04-03
AU2010300033A1 (en) 2012-03-22
PT2480658T (pt) 2017-11-13
ZA201202836B (en) 2012-12-27
AU2010300033B2 (en) 2015-01-22
HUE038557T2 (hu) 2018-10-29
EP2480560A1 (en) 2012-08-01
DK2480560T3 (da) 2018-04-16
CN107129973A (zh) 2017-09-05
IL257261A (en) 2018-03-29
KR20190050862A (ko) 2019-05-13
NO2480658T3 (da) 2018-02-03
SG178918A1 (en) 2012-04-27
BR112012006415B1 (pt) 2020-04-28
US20120178149A1 (en) 2012-07-12
JP5554414B2 (ja) 2014-07-23
SG178947A1 (en) 2012-04-27
CA2772964A1 (en) 2011-03-31
NZ598508A (en) 2014-02-28
EP2480658A4 (en) 2013-02-27
HRP20171564T1 (hr) 2017-11-17
PL2480560T3 (pl) 2018-06-29
NZ598481A (en) 2014-02-28
EP2480560A4 (en) 2013-01-23
IL218393A0 (en) 2012-04-30
JP2013505272A (ja) 2013-02-14
IL218422A0 (en) 2012-04-30
KR20180026562A (ko) 2018-03-12
RU2012115996A (ru) 2013-10-27
IL257261B (en) 2020-03-31
EP2480560B1 (en) 2018-02-21
WO2011035423A1 (en) 2011-03-31
CA2772962A1 (en) 2011-03-31
BR112012006414A8 (pt) 2017-10-10
CN102549008A (zh) 2012-07-04
BR112012006414B1 (pt) 2020-09-15
HUE036776T2 (hu) 2018-07-30
CA2772964C (en) 2020-10-27
HUE058165T2 (hu) 2022-07-28
MX2012003372A (es) 2012-05-29
IL270661B (en) 2021-12-01
PL2480658T3 (pl) 2017-12-29
AR078433A1 (es) 2011-11-09
CN107090021A (zh) 2017-08-25
BR112012006415A2 (pt) 2016-11-16
ES2662778T3 (es) 2018-04-09
ZA201202835B (en) 2015-08-26
HRP20180509T1 (hr) 2018-05-04
HRP20220478T1 (hr) 2022-05-27
RU2567012C2 (ru) 2015-10-27
EP2480658B1 (en) 2017-09-06
AU2010300034B2 (en) 2015-07-30
EP2480658A1 (en) 2012-08-01
KR101773431B1 (ko) 2017-09-12
BR112012006414A2 (pt) 2016-11-16
JP5551780B2 (ja) 2014-07-16
JP2013505025A (ja) 2013-02-14
RU2012115661A (ru) 2013-10-27
TR201803560T4 (tr) 2019-01-21
PL3354657T3 (pl) 2022-05-09
KR20120072371A (ko) 2012-07-03
AU2010300034A1 (en) 2012-03-22
CA2772962C (en) 2013-04-02
SI2480658T1 (sl) 2017-11-30
DK2480658T3 (da) 2017-11-06
EP3354657B1 (en) 2022-01-26
ES2911037T3 (es) 2022-05-17
US20130067807A1 (en) 2013-03-21
US11833200B2 (en) 2023-12-05
NO2480560T3 (da) 2018-07-21
MY164704A (en) 2018-01-30
SI2480560T1 (en) 2018-04-30
US11826419B2 (en) 2023-11-28
MY158475A (en) 2016-10-14
PT3354657T (pt) 2022-05-06
RU2579903C2 (ru) 2016-04-10
AR078432A1 (es) 2011-11-09
KR20120093223A (ko) 2012-08-22

Similar Documents

Publication Publication Date Title
IN2012DN02637A (da)
WO2012151524A3 (en) Lignin production from lignocellulosic biomass
PL2167631T3 (pl) Instalacja biogazu i sposób wytwarzania biogazu z odnawialnych surowców zawierających ligninę
MX2013002140A (es) Metodo para recuperar lignina.
EA201200772A1 (ru) Способ получения полых микросфер
WO2012135659A3 (en) Methods for enhancing the degradation or conversion of cellulosic material
MX2011013700A (es) Cepa talaromyces y composiciones de enzimas.
MY162541A (en) Method of manufacturing filter aid
WO2012126123A8 (en) Method of recovering plant-derived proteins
DK2041151T3 (da) Fremgangsmåde til fremstilling af et glycosid af et mono- eller diacylglycerolprodukt fra et plantemateriale
ZA201107726B (en) Micro-alga belonging to genus navicula,process for production of oil by culture of the micro-alga,and oil collection from the micro-alga
MX349836B (es) Deshidratacion de material de biomasa que comprende polisacarido, metodo para extraer polisacarido de material de biomasa y material de biomasa deshidratada.
WO2011051977A3 (en) Process for biodiesel production from a yeast strain
GB201012113D0 (en) Method for recovering molybdenum and cobalt
WO2010058427A3 (en) Process for production and purification of polymyxin b sulfate
MY184409A (en) Production of bio-butanol and related products
RU2014151418A (ru) Получение ферментов для лигноцеллюлозной биомассы
WO2012057438A3 (ko) 1,3,5-트리옥산의 제조방법
WO2011124815A3 (fr) Procede d'obtention d'un produit fermentescible a partir d'une biomasse lignocellulosique polluee
WO2012089843A3 (en) Extraction of scenedesmus cell components
EP2509453A4 (en) NUTRITIONAL COMPOSITION AND METHODS OF MAKING AND USING THE SAME
TH124382B (th) วิธีการของการเตรียมอนุภาคคล้ายไวรัสซึ่งได้มาจากพืช
WO2010100066A3 (de) Windkraftanlage und zugehöriges herstellungsverfahren
WO2011057947A3 (en) Method for producing silicon
TH124382A (th) วิธีการของการเตรียมอนุภาคคล้ายไวรัสซึ่งได้มาจากพืช